Mintech

452200 · KOSDAQ · ₩452200 · 민테크

₩1,450▲ ₩36 (2.55%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −51.99%
Market cap
₩35B
Enterprise value
₩42B
P/E
—
P/B
1.2×
Dividend yield
0.0%
ROE
−24.4%
Net margin
−31.5%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−72.1% from the high

₩980Today: ₩1,408 – ₩1,484₩5,200

Returns

  • 1W−8.3%
  • 1M−14.6%
  • 3M+21.2%
  • 6M−48.8%
  • YTD−38.8%
  • 1Y−52.0%
Volume today
21,237
0.4× the 20-day average
Traded today
₩31M
Listed shares
24,332,800
EPS (12 months)
−₩290
Earnings yield −20.0%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

32Quiet
  • BuzzQuietBuzz 32 of 100 (50 is a normal day for this stock).
  • MomentumWeak-14.5% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Mintech stock overview

Mintech (민테크, KRX: 452200) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops inspection and diagnostic solutions for lithium-ion batteries, the core components of electric vehicles and energy storage systems. Its shares closed at ₩1,450 on Oct 27, 2026, up 2.55% on the day, giving it a market value of ₩35B.

Key facts

Market cap
₩35B
Sector
Medical & precision devices
Latest price change
+2.55%
As of
Oct 27, 2026
Main business
The company develops inspection and diagnostic solutions for lithium-ion batteries, the core components of electric vehicles and energy storage systems.

Quick answers about Mintech

What does Mintech do?
The company develops inspection and diagnostic solutions for lithium-ion batteries, the core components of electric vehicles and energy storage systems. It was founded in 2015 and uses electrochemical impedance spectroscopy to diagnose battery condition, detect defects and grade batteries across the cell manufacturing, pack manufacturing, in-use and end-of-life stages. Its main products are battery diagnostic systems and charge-discharge test equipment, which it sells mainly as custom-built products directly to customers such as domestic electric vehicle and battery manufacturers, and it is pursuing sales in the Americas and Europe.
What is the market cap of Mintech?
The market capitalisation of Mintech was ₩35B at the close on Oct 27, 2026.
Who are the largest shareholders of Mintech?
According to the latest official filings, the largest reported holders are Hong Yeong-jin (11.83%, as of Apr 27, 2026); Myeong Hui-gyeong (10.55%, as of Apr 21, 2026); LG Energy Solution (4.95%, as of Oct 16, 2025).
When is the next earnings report from Mintech?
Korean companies rarely announce results dates in advance. Based on when Mintech filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

The company develops inspection and diagnostic solutions for lithium-ion batteries, the core components of electric vehicles and energy storage systems. It was founded in 2015 and uses electrochemical impedance spectroscopy to diagnose battery condition, detect defects and grade batteries across the cell manufacturing, pack manufacturing, in-use and end-of-life stages. Its main products are battery diagnostic systems and charge-discharge test equipment, which it sells mainly as custom-built products directly to customers such as domestic electric vehicle and battery manufacturers, and it is pursuing sales in the Americas and Europe.

Written by AI from the company's latest annual report.

Korean name
민테크
CEO
홍영진
Founded
Jun 2015
Listed
May 2024
Listed shares
24,332,800
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Mintech / 민테크 / 452200 / KRX:452200

Source: KRX statistical information